Additional file 1 of Congenital anomalies after first-trimester dydrogesterone therapy during in vitro fertilization

Supplementary Material 1: Supplementary Table S1. Detailed Incidence of each classification of congenital anomalies of the study cohort according to the status of maternal DYG therapy. Supplementary Table S2. Baseline characteristics of the study cohort according to the method of maternal DYG therapy. Supplementary Table S3. Congenital anomalies of the musculoskeletal system according to the method of maternal DYG therapy. Supplementary Table S4. Multivariate logistic regression analysis for factors influencing the occurrence of congenital anomalies. Supplementary Table S5. Pregnancies terminated following prenatal diagnosis according to the method of maternal DYG therapy